Literature DB >> 8811094

Triplex-forming oligonucleotides trigger conformation changes of a target hairpin sequence.

E Brossalina1, E Demchenko, Y Demchenko, V Vlassov, J J Toulmé.   

Abstract

We used a DNA duplex formed between the 5' end of a 69mer (69T) and an 11mer (OL7) as a substrate for BamHI. The former oligonucleotide folds into a hairpin structure, the stem of which contains a stretch of pyrimidines in one strand and consequently a stretch of purines in the other strand. The oligomer 69T was used as a target for complementary oligodeoxypyrimidines made of 10 nt (OL1), 16 nt (OL5) or 26 nt (OL2) which can engage the same 10 pyrimidine-purine-pyrimidine triplets with the 69T hairpin stem. Although the binding site of OL7 did not overlap that of OL1, OL2 or OL5, the BamHI activity on 69T-OL7 complexes was drastically modified in the presence of these triplex-forming oligomers: OL1 abolished the cleavage by BamHI whereas OL5 and OL2 strongly increased it. Using footprinting assays and point-mutated oligonucleotides we demonstrated that these variations were due to different conformations of the 69T-OL7 complex induced by the binding of oligomers OL1, OL2 or OL5. Therefore, oligonucleotides can act as structural switchers, offering one additional mode for modulating gene expression.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8811094      PMCID: PMC146096          DOI: 10.1093/nar/24.17.3392

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  36 in total

Review 1.  Specific regulation of gene expression by antisense, sense and antigene nucleic acids.

Authors:  C Hélène; J J Toulmé
Journal:  Biochim Biophys Acta       Date:  1990-06-21

Review 2.  Translational suppression in gene expression in retroviruses and retrotransposons.

Authors:  T Jacks
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

3.  Improved predictions of secondary structures for RNA.

Authors:  J A Jaeger; D H Turner; M Zuker
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

4.  Relative stability of parallel- and antiparallel-stranded duplex DNA.

Authors:  M W Germann; B W Kalisch; J H van de Sande
Journal:  Biochemistry       Date:  1988-11-01       Impact factor: 3.162

5.  Role of RNase H in hybrid-arrested translation by antisense oligonucleotides.

Authors:  R Y Walder; J A Walder
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

6.  Enzymatic amplification of translation inhibition of rabbit beta-globin mRNA mediated by anti-messenger oligodeoxynucleotides covalently linked to intercalating agents.

Authors:  C Cazenave; N Loreau; N T Thuong; J J Toulmé; C Hélène
Journal:  Nucleic Acids Res       Date:  1987-06-25       Impact factor: 16.971

7.  Effect of RNA secondary structure and modified bases on the inhibition of trypanosomatid protein synthesis in cell free extracts by antisense oligodeoxynucleotides.

Authors:  P Verspieren; N Loreau; N T Thuong; D Shire; J J Toulmé
Journal:  Nucleic Acids Res       Date:  1990-08-25       Impact factor: 16.971

8.  Inhibition of DNA binding proteins by oligonucleotide-directed triple helix formation.

Authors:  L J Maher; B Wold; P B Dervan
Journal:  Science       Date:  1989-08-18       Impact factor: 47.728

9.  Inhibition of restriction endonuclease cleavage via triple helix formation by homopyrimidine oligonucleotides.

Authors:  J C François; T Saison-Behmoaras; N T Thuong; C Hélène
Journal:  Biochemistry       Date:  1989-12-12       Impact factor: 3.162

10.  Site-specific inhibition of EcoRI restriction/modification enzymes by a DNA triple helix.

Authors:  J C Hanvey; M Shimizu; R D Wells
Journal:  Nucleic Acids Res       Date:  1990-01-11       Impact factor: 16.971

View more
  1 in total

1.  Selective inhibition of cell-free translation by oligonucleotides targeted to a mRNA hairpin structure.

Authors:  R Le Tinévez; R K Mishra; J J Toulmé
Journal:  Nucleic Acids Res       Date:  1998-05-15       Impact factor: 16.971

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.